V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007109 | 300005182 | 1.43 | 63 | Disease modification (D) | 2016-10-29 | 2016-11-25 | Oxaliplatin + Modified de Gramont | N | N | 300008235 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300007110 | 300005182 | 1.85 | 105.3 | Adjuvant (A) | 2016-10-15 | 2016-11-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 300008235 | CAPECITABINE + OXALIPLATIN |
| 300007111 | 300005183 | null | 76.8 | Palliative (P) | 2017-10-07 | 2017-10-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300008487 | ECX |
| 300007112 | 300005184 | 1.67 | 51.3 | Palliative (P) | 2018-09-03 | 2018-09-07 | Cisplatin | N | N | 300008495 | DABRAFENIB + TRAMETINIB |
| 300007113 | 300007159 | 1.52 | 67.45 | Adjuvant (A) | 2018-10-29 | 2019-05-17 | Oxaliplatin + Modified de Gramont | N | N | 300008495 | IPILIMUMAB + NIVOLUMAB |
| 300007114 | 300007159 | 1.59 | 45.4 | Neo-adjuvant (N) | 2016-03-26 | 2016-03-26 | Cetuximab + Radiotherapy Maint | 02 | Y | 300008495 | CETUXIMAB + RT |
| 300007115 | 300005186 | 1.85 | 60.9 | Disease modification (D) | 2016-07-05 | 2016-07-20 | CISPLATIN + FLUOROURACIL | N | N | 300008841 | NAB-PACLITAXEL |
| 300007116 | 300005187 | 1.74 | 56.9 | Palliative (P) | 2016-07-21 | 2016-07-23 | Carboplatin + Etoposide iv&po | N | N | 300008989 | CISPLATIN + FLUOROURACIL |
| 300007117 | 300005188 | 1.67 | null | Palliative (P) | 2015-06-26 | 2015-08-26 | Cisplatin 7 day | 02 | N | 300009006 | CAPECITABINE |
| 300007118 | 300005189 | 1.55 | 59.75 | Palliative (P) | 2017-11-30 | 2018-01-18 | Cetuximab + Radiotherapy Maint | N | Y | 300009034 | CAPECITABINE + CISPLATIN + RT |
| 300007119 | 300005190 | 1.67 | 82.9 | Palliative (P) | 2018-11-17 | 2018-11-17 | FCarboSt | 02 | N | 300009053 | CARBOPLATIN |
| 300007120 | 300005190 | 1.78 | 82.1 | Palliative (P) | 2016-07-18 | 2016-09-12 | Cisplatin 7 day | 02 | Y | 300009053 | CETUXIMAB + RT |
| 300007121 | 300005191 | 1.58 | 65.9 | Palliative (P) | 2017-07-23 | 2017-08-12 | Oxaliplatin + Modified de Gramont | 01 | N | 300009300 | FLUOROURACIL |
| 300007122 | 300005191 | 1.64 | 81.4 | Palliative (P) | 2016-10-19 | 2018-01-12 | Trial Unspecified | 02 | N | 300009300 | TRIAL |
| 300007123 | 300005191 | null | 74 | Palliative (P) | 2017-12-17 | 2017-12-22 | Cisplatin | 02 | N | 300009300 | CETUXIMAB |
| 300007124 | 300005192 | 1.46 | 61.4 | Curative (C) | 2017-07-06 | 2017-07-25 | CISPLATIN + FLUOROURACIL | 02 | N | 300009901 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007125 | 300005192 | 160.6 | 44.6 | Palliative (P) | 2017-01-23 | 2017-02-20 | CARBOPLATIN | 02 | N | 300009901 | CARBOPLATIN + PACLITAXEL |
| 300007126 | 300005193 | 1.59 | null | Palliative (P) | 2017-05-19 | 2017-07-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300010197 | CISPLATIN + DOX + ETOPOSIDE |
| 300007127 | 300005194 | 1.64 | null | Palliative (P) | 2018-07-24 | 2018-07-24 | DE-ESCALATE TRIAL | 2 | null | 300010315 | DE-ESCALATE TRIAL |
| 300007128 | 300005195 | 1.61 | 64.9 | Palliative (P) | 2017-08-11 | 2017-08-19 | Folfirinox | N | N | 300010351 | CARBO + FLUOROURACIL |
| 300007129 | 300005196 | 1.65 | 65 | Palliative (P) | 2015-09-02 | 2015-09-02 | Cetuximab 7 day (>Cycle 2) | Y | null | 300010643 | OXALIPLATIN + MDG |
| 300007130 | 300005197 | 1.83 | 79.5 | null | 2016-04-09 | 2016-05-13 | Cisplatin +Fluorouracil (3 wk) | N | Y | 300010835 | GEMCITABINE + RT |
| 300007131 | 300005199 | 1.7 | 76.6 | Palliative (P) | 2017-07-26 | 2017-07-27 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 300010901 | CETUXIMAB + RT |
| 300007132 | 300005200 | 1.5 | 77.2 | Palliative (P) | 2019-08-12 | 2019-08-13 | CARBOPLATIN + PACLITAXEL | null | N | 300011142 | GEMCARBO |
| 300007133 | 300005201 | 1.69 | 91 | null | 2017-09-19 | 2017-09-22 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300011224 | OXALIPLATIN + MDG |
| 300007134 | 300005203 | 1.73 | 81 | Palliative (P) | null | 2016-09-11 | GEMCITABINE + NAB PACLITAXEL | N | N | 300011347 | TRIAL |
| 300007135 | 300005204 | 1.7 | null | Curative (C) | 2017-04-07 | 2017-04-07 | CARBOPLATIN + RT | 2 | Y | 300011708 | GEMCITABINE + RT |
| 300007136 | 300005204 | null | 82.4 | Palliative (P) | 2018-09-05 | 2018-09-07 | Carboplatin + Cetux + FU (Cycle 1) | 2 | N | 300011708 | CARBOPLATIN + DOCETAXEL |
| 300007137 | 300005205 | 1.63 | 57.8 | Palliative (P) | 2018-05-13 | 2018-05-18 | NIVOLUMAB | N | N | 300011918 | FLUOROURACIL |
| 300007138 | 300005209 | 1.7 | 59 | Palliative (P) | 2018-02-26 | 2018-02-26 | CARBOPLATIN + RT | N | Y | 300012308 | CETUXIMAB + RT |
| 300007139 | 300005209 | 1.79 | null | Palliative (P) | 2018-03-21 | 2018-06-15 | Cetuximab 7 day (Cycle 1) | N | N | 300012308 | CETUXIMAB |
| 300007140 | 300005209 | 1.7 | 88.3 | Palliative (P) | 2014-10-09 | 2014-10-15 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 300012308 | CISPLATIN |
| 300007141 | 300005210 | 1.64 | 62.3 | null | 2018-03-18 | 2018-04-02 | Pemetrexed | N | null | 300012874 | CETUXIMAB |
| 300007142 | 300005212 | 1.73 | 56.4 | Palliative (P) | 2014-04-08 | 2014-04-13 | PACLITAXEL | N | N | 300013851 | CAPECITABINE |
| 300007143 | 300005212 | 1.55 | 57 | Adjuvant (A) | 2017-03-09 | 2017-03-09 | Cetuximab 7 day (>Cycle 2) | N | Y | 300013851 | CETUXIMAB + RT |
| 300007144 | 300005213 | 1.61 | 72 | Palliative (P) | 2014-09-30 | 2014-12-24 | Irinotecan + Modified De Gramont | N | N | 300014246 | FLUOROURACIL |
| 300007145 | 300005214 | 1.58 | 92.5 | Palliative (P) | 2016-04-09 | 2016-04-21 | Temozolomide 200mg/m2 | 02 | N | 300014328 | IRINOTECAN + MDG |
| 300007146 | 300005214 | 1.64 | 88.7 | Adjuvant (A) | 2015-10-10 | 2015-11-14 | Oxaliplatin + Modified de Gramont | 02 | N | 300014328 | TRIAL |
| 300007147 | 300005214 | 1.6 | null | Palliative (P) | 2014-10-22 | 2014-10-23 | Capecitabine | 02 | N | 300014328 | CARBOPLATIN + PACLITAXEL |
| 300007148 | 300005216 | 1.66 | 74.5 | Adjuvant (A) | 2015-03-05 | 2015-03-17 | CISPLATIN + FLUOROURACIL | 02 | N | 300015050 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 300007149 | 300005217 | 1.63 | 40 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-17 | Capecitabine + Oxaliplatin 21day | N | N | 300015601 | CARBOPLATIN + PACLITAXEL |
| 300007150 | 300005218 | null | null | Curative (C) | 2016-05-24 | 2016-06-11 | Carboplatin AUC 6 - 10 | N | Y | 300015601 | CAPECITABINE + IRINOTECAN |
| 300007151 | 300008165 | 1.58 | 54.2 | Curative (C) | 2016-07-15 | 2016-07-25 | Cisplatin | 2 | Y | 300016099 | CETUXIMAB |
| 300007152 | 300008165 | 1.73 | 57.95 | Palliative (P) | 2018-04-03 | 2018-07-04 | IVA | 2 | N | 300016099 | PACLITAXEL |
| 300007153 | 300005219 | 1.8 | 100.65 | Palliative (P) | 2015-04-19 | 2015-04-20 | Gemcitabine + Capecitabine | N | N | 300017310 | CETUXIMAB |
| 300007154 | 300005219 | null | 56.3 | Palliative (P) | 2015-12-08 | 2016-02-21 | Trial Unspecified | N | N | 300017310 | CARBOPLATIN + RT |
| 300007155 | 300007871 | 1.91 | 76 | Palliative (P) | 2016-02-18 | 2016-02-19 | CETUXIMAB | null | null | 300017755 | ESPAC TRIAL |
| 300007156 | 300008289 | null | 49.6 | Palliative (P) | 2017-12-09 | 2017-12-28 | Cisplatin 7 day | N | Y | 300017755 | CARBOPLATIN + RT |
| 300007157 | 300008362 | 1.68 | 54.8 | Palliative (P) | 2018-01-12 | 2018-01-22 | CYCLOPHOSPHAMIDE | 02 | N | 300018832 | GEMCARBO |
| 300007158 | 300005220 | 1.74 | 62.2 | Palliative (P) | 2015-05-09 | 2015-05-09 | CARBOPLATIN + RT | N | N | 300019084 | CAPECITABINE + GEMCITABINE |